Close

Analyst Ratings for Cerevel Therapeutics (CERE)

CERE Rating Summary

CERE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CERE
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $40.86 (+22.9%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/2/2022 JPMorgan Jessica Fye New Coverage Overweight
(N/A)
49.00
(N/A)
26.29
(33.25)
26.47% Details
7/7/2022 Mizuho Securities
» Updated 8/3/2022
Graig Suvannavejh New Coverage Neutral
(N/A)
27.00
(30.00)
30.63
(33.25)
8.55% Details
Like CERE Ratings? Also take a look at KRTX, NBIX

CERE Ratings News